The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Levothyroxine Teva 25 micrograms Tablets



Teva Pharma B.V.PA0749/143/001

Main Information

Trade NameLevothyroxine Teva 25 micrograms Tablets
Active SubstancesLevothyroxine sodium
Dosage FormTablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/143/001

Group Information

ATC CodeH03AA Thyroid hormones
H03AA01 levothyroxine sodium

Status

License statusAuthorised
Licence Issued23/11/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back